Disrupting Pharmacy Benefit Management: RxParadigm Launches to Restore Drug Industry Competitiveness and Reduce the Costs of Prescription Drugs for Americans
Mesfin Tegenu negotiated billions of dollars of prescription drug contracts with leading pharmaceutical companies over a 25-year career.
- Mesfin Tegenu negotiated billions of dollars of prescription drug contracts with leading pharmaceutical companies over a 25-year career.
- RxParadigm will focus on increasing competition in a powerful, yet little understood channel, Pharmacy Benefit Management (PBM).
- Originally conceived in the 1960s, PBMs were created to aggregate the buying power of several insurance companies to drive down drug prices.
- Net spending on outpatient prescription drugs is expected to rise by more than 5% annually between 2020 and 2028 .